Controllable self-assembled DNA nanomachine enable homogeneous rapid electrochemical one-pot assay of lung cancer circulating tumor cells
Biosensors and Bioelectronics · 2024-02 · 246 · 115865
DOI: 10.1016/j.bios.2023.115865 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2024-02. Verfasst von Chengxin Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Department of Laboratory Medicine, Med+X Center for Manufacturing, Out-patient Department, National Clinical Research…. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating, Lung Neoplasms, Aptamers, Nucleotide, Biosensing Techniques. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
A homogeneous rapid (45 min) one-pot electrochemical (EC) aptasensor was established to quantitatively detect circulating tumor cells (CTCs) in lung cancer patients using mucin 1 as a marker. The core of this study is that the three single-stranded DNA (Y1, Y2, and Y3) could be hybridized to form Y-shaped DNA (Y-DNA) and further self-assemble to form DNA nanosphere. The aptamer of mucin 1 could be complementary and paired with Y1, thus disrupting the conformation of the DNA nanosphere. When mucin 1 was present, the aptamer combined specifically with mucin 1, thus preserving the DNA nanosphere structure. Methylene blue (MB) acted as a signal reporter, which could be embedded between two base pairs in the DNA nanosphere to form a DNA nanosphere-MB complex, reducing free MB and resulting in a lower electrochemical signal. The results demonstrated that the linear ranges for mucin 1 and A549 cells were 1 ag/mL-1 fg/mL and 1-100 cells/mL, respectively, with minimum detectable concentrations were 1 ag/mL and 1 cell/mL, respectively. The quantitative analysis of CTCs in 44 clinical blood samples was performed, and the results were consistent with the computerized tomography (CT) images, pathological findings and folate receptor-polymerase chain reaction (FR-PCR) kits. The receiver operating characteristic (ROC) curve exhibited an area under the curve (AUC) value of 0.970. The assay revealed 100% specificity and 94.1% sensitivity. It is believed that this electrochemical aptasensor could provide a new approach to detect CTCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Department of Laboratory Medicine, Med+X Center for Manufacturing, Out-patient Department, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Cheng…
Zitieren
APA
Liu, C., Shen, X., Yan, L., Qu, R., Wang, Y., He, Y., Zhan, Z., Chen, P., & Lin, F. (2024). Controllable self-assembled DNA nanomachine enable homogeneous rapid electrochemical one-pot assay of lung cancer circulating tumor cells. Biosensors and Bioelectronics, 246, 115865. https://doi.org/10.1016/j.bios.2023.115865
Vancouver
Liu C, Shen X, Yan L, Qu R, Wang Y, He Y, et al. Controllable self-assembled DNA nanomachine enable homogeneous rapid electrochemical one-pot assay of lung cancer circulating tumor cells. Biosensors and Bioelectronics. 2024;246:115865. doi:10.1016/j.bios.2023.115865
BibTeX
@article{Liu2024,
author = {Liu, Chengxin and Shen, Xu and Yan, Li and Qu, Runlian and Wang, Yue and He, Yaqin and Zhan, Zixuan and Chen, Piaopiao and Lin, Feng},
title = {Controllable self-assembled DNA nanomachine enable homogeneous rapid electrochemical one-pot assay of lung cancer circulating tumor cells},
journal = {Biosensors and Bioelectronics},
year = {2024},
volume = {246},
pages = {115865},
doi = {10.1016/j.bios.2023.115865}
}
EUVIMED